Breast Fibroadenoma
1
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
TheraclionFrance - Malakoff
3 programsECHOPULSEN/A1 trial
EchopulseN/A1 trial
EchopulseN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
InsightecExAblate 2000
TheraclionECHOPULSE
TheraclionEchopulse
TheraclionEchopulse
Clinical Trials (4)
Total enrollment: 257 patients across 4 trials
MR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas
Start: Jan 2003Est. completion: Oct 2005102 patients
Phase 3Terminated
Treatment of Breast Fibroadenoma Targeted Tissue With HIFU
Start: Jan 2017Est. completion: Apr 2026113 patients
N/ACompleted
Treatment of Breast Fibroadenoma With FastScan HIFU
Start: Jun 2015Est. completion: Dec 201815 patients
N/ACompleted
Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)
Start: Dec 2013Est. completion: Jan 201727 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.